Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF is an ETF issued by Amplify Holding Co. LLC on May 21 2024. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care". As of today, the price of THNR ETF according to its net asset value is premiumed at 0.10%. While the total value of the fund shows $636.08K increase compared to the previous month, its price is traded daily at a decrease of -0.07%. The annual dividend yield of THNR ETF is 0.00%, whereas its main asset area is Developed markets. THNR ETF, whose 24-hour total volume is $2.89K, has experienced a $551.74K cash inflow in the last month. In addition, Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF's 3-month net asset value total return is 6.34%.